Berkshire Biomedical is developing the COPA™ system, a medication dispensing system designed to combine security, compliance support, remote monitoring, and data analytics with accurate oral liquid dispensing. The system aims to enhance personalized medication delivery and adherence through dual biometric identification technology.

Berkshire Biomedical

Berkshire Biomedical Corporation | 242 followers on LinkedIn. Developing Drug dispensing Technology to Accurately and Precisely Deliver Oral Liquid Drugs to Only the Intended Users | Berkshire Biomedical Corporation is a privately held medical device company.   Berkshire is pioneering the use of biometric technologies, combined with cloud-based and physician-enabled remote management systems, to provide precise and accurate personalized medication delivery to only the Authenticated Intended User (AIU™).

The Company’s lead product under development, the Computerized Oral Prescription Administration System (COPA™), is a hand-held, automated, personalized oral liquid dispensing system designed and intended to deliver controlled and non-controlled liquid oral medications to only the Authenticated Intended User upon confirmation of dual biometric identifications (fingerprint and dentition).

BERK

COM:BERKSHIREBIOMEDICAL

Berkshire Biomedical